Big News Gains: Beasley Broadcast (NASDAQ:BBGI), Principal Financial (NYSE:PFG), Greatbatch (NYSE:GB), The Toronto-Dominion Bank (NYSE:TD), Opexa Therapeutics (NASDAQ:OPXA)

Beasley Broadcast Group Inc. (NASDAQ:BBGI) shares moved down -2.16% in last trading session and ended the day at $4.07. BBGI Gross Margin is 29.80% and its has a return on assets of 13.30%. Beasley Broadcast Group Inc. (NASDAQ:BBGI) quarterly performance is -9.72%.

Beasley Broadcast Group, Inc. is a radio broadcasting company. The Company’s primary business is operating radio stations throughout the United States. The Company owns and operates 53 radio stations in Atlanta, Georgia; Augusta, Georgia; Boston, Massachusetts; Charlotte, NC, Fayetteville, North Carolina; Fort Myers-Naples, Florida; Greenville-New Bern-Jacksonville, North Carolina; Las Vegas, Nevada; Philadelphia, Pennsylvania; Tampa-Saint Petersburg, Florida; West Palm Beach-Boca Raton, Florida, and Wilmington, Delaware.

Beasley Broadcast Group Inc. (NASDAQ:BBGI), announced that its Board of Directors declared a quarterly cash dividend of $0.045 per share of its Class A and Class B common stock. The dividend is payable on October 9, 2015, to shareholders of record on September 30, 2015.

Principal Financial Group, Inc. is an investment management company. The Company offers businesses, individuals and institutional clients a range of financial products and services, including retirement, asset management and insurance through its financial services companies. Its segments include Retirement and Investor Services, Principal Global Investors, Principal International, and U.S. Insurance Solutions.

Principal Financial Group (NYSE:PFG) has received a “BBB” credit rating from analysts at Morningstar. The research firm’s “BBB” rating indicates that the company is a moderate default risk. They also gave their stock a three star rating.

Greatbatch, Inc. (NYSE:GB) shares moved up 0.21% in last trading session and ended the day at $57.06. GB Gross Margin is 33.30% and its has a return on assets of 4.80%. Greatbatch, Inc. (NYSE:GB) quarterly performance is 7.42%.

Greatbatch, Inc. is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise. Greatbatch Medical’s products include medical devices and components for the cardiac, neuromodulation, orthopedics, portable medical, vascular and energy markets.

Greatbatch, Inc. (NYSE:GB) announced Thursday that it will acquire Lake Region Medical for approximately $1.73 billion in cash and stock. Both companies have Minnesota operations. The combined company will have more than 9,000 workers and revenues of $1.5 billion, making it one of the largest medical device OEM suppliers in the world serving the cardiac, neuromodulation, vascular, orthopaedics and advanced surgical markets

The Toronto-Dominion Bank (NYSE:TD) caters to the Financial space. It has a net profit margin of 31.20% and weekly performance is 4.80%. On the last day of trading company shares ended up $39.99. The Toronto-Dominion Bank (NYSE:TD) distance from 50-day simple moving average (SMA50) is -1.77%.

The Toronto-Dominion Bank and its subsidiaries are collectively known as TD Bank Group (TD). TD offers a full range of financial products and services to approximately 22 million customers around the world through three key business lines: Canadian Retail including TD Canada Trust, TD Commercial Banking, TD Auto Finance (Canada), TD Wealth (Canada) and TD Insurance; U.S. Retail including TD Bank, America’s Most Convenient Bank, TD Auto Finance (U.S.), TD Wealth (U.S.) and TD’s investment in TD Ameritrade and Wholesale Banking including TD Securities.

Canada’s second-largest lender The Toronto-Dominion Bank (NYSE:TD) Thursday reported that its third-quarter net income rose to C$2.266 billion from last year’s C$2.107 billion. The Group’s earnings per share increased to C$1.19 from C$1.11 a year ago. Adjusted net income for the quarter was C$2.285 billion or C$1.20 per share. On average, 14 analysts polled by Thomson Reuters expected earnings per share of C$1.18 for the quarter. Analysts’ estimates typically exclude special items.

Opexa Therapeutics, Inc. (NASDAQ:OPXA) shares advanced 0.53% in last trading session and ended the day at $0.38. OPXA has a return on assets of -97.40%. Opexa Therapeutics, Inc. (NASDAQ:OPXA) quarterly performance is -24.00%.

Opexa Therapeutics, Inc. (Opexa) is a biopharmaceutical company engaged in developing a personalized immunotherapy with the potential to treat illnesses, including multiple sclerosis (MS). MS is an inflammatory autoimmune disease of the central nervous system (CNS), which is made up of the brain, spinal cord and optic nerves, with a clinically heterogeneous and unpredictable course that persists for decades.

Opexa Therapeutics, Inc. (NASDAQ:OPXA) announced that Neil K. Warma, President and Chief Executive Officer, will present at Sidoti Emerging Growth Conference, on
Wednesday, September 2, 2015 @ 10:40am EDT, at Marriott Marquis in Times Square, New York, New York.